speb/financial-data huggingface dataset:
CLNE cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -1700000.00
CLNE income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
CLNE cash_flow (annual, 2022-12-31) — Stock Based Compensation: 50775000.00
CLNE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 719993000.00
CLNE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 649750000.00
CLNE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CLNE income_statement (annual, 2022-12-31) — Tax Provision: 220000.00
CLNE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CLNE balance_sheet (annual, 2022-12-31) — Taxes Receivable: 9462000.00
CLNE balance_sheet (annual, 2022-12-31) — Total Assets: 1082357000.00
CLNE balance_sheet (annual, 2022-12-31) — Total Capitalization: 865464000.00
CLNE balance_sheet (annual, 2022-12-31) — Total Debt: 201763000.00
CLNE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 727471000.00
CLNE income_statement (annual, 2022-12-31) — Total Expenses: 471871000.00
CLNE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 354886000.00
CLNE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 610637000.00
CLNE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 206740000.00
CLNE income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -51707000.00
CLNE income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
CLNE income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CLNE balance_sheet (annual, 2022-12-31) — Working Capital: 323574000.00
CLNE income_statement (annual, 2022-12-31) — Write Off: 0.00
CLNE income_statement (annual, 2023-12-31) — +Operating Expense: 112265000.00
CLNE income_statement (annual, 2023-12-31) — +Total Revenue: 425159000.00
CLNE balance_sheet (annual, 2023-12-31) — Accounts Payable: 56995000.00
CLNE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 98426000.00
CLNE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -492140000.00
CLNE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1658339000.00
CLNE balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -1475000.00
CLNE cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 634000.00
CLNE income_statement (annual, 2023-12-31) — Basic Average Shares: 222904785.00
CLNE income_statement (annual, 2023-12-31) — Basic EPS: -0.45
CLNE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 125950000.00
CLNE cash_flow (annual, 2023-12-31) — Capital Expenditure: -121282000.00
CLNE balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 99349000.00
CLNE balance_sheet (annual, 2023-12-31) — Capital Stock: 22000.00
CLNE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 104944000.00
CLNE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 263130000.00
CLNE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 139121000.00
CLNE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -202013000.00
CLNE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 43777000.00
CLNE cash_flow (annual, 2023-12-31) — Change In Account Payable: 14770000.00
CLNE cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -18000.00
CLNE cash_flow (annual, 2023-12-31) — Change In Inventory: -11391000.00
CLNE cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -3957000.00
CLNE cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -883000.00
CLNE cash_flow (annual, 2023-12-31) — Change In Payable: 14770000.00
CLNE cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 14752000.00
CLNE cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 510000.00
CLNE cash_flow (annual, 2023-12-31) — Change In Receivables: -7711000.00
CLNE cash_flow (annual, 2023-12-31) — Change In Working Capital: -8680000.00
CLNE cash_flow (annual, 2023-12-31) — Changes In Cash: -19115000.00
CLNE balance_sheet (annual, 2023-12-31) — Common Stock: 22000.00
CLNE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 726770000.00
CLNE cash_flow (annual, 2023-12-31) — Common Stock Issuance: 242000.00
CLNE cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
CLNE balance_sheet (annual, 2023-12-31) — Construction In Progress: 125389000.00
CLNE income_statement (annual, 2023-12-31) — Cost Of Revenue: 389294000.00
CLNE balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 86219000.00
CLNE balance_sheet (annual, 2023-12-31) — Current Assets: 470175000.00
CLNE balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 8445000.00
CLNE balance_sheet (annual, 2023-12-31) — Current Debt: 38000.00
CLNE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 8483000.00
CLNE balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 4936000.00
CLNE balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 4936000.00
CLNE balance_sheet (annual, 2023-12-31) — Current Liabilities: 163823000.00
CLNE cash_flow (annual, 2023-12-31) — Deferred Income Tax: -515000.00
CLNE cash_flow (annual, 2023-12-31) — Deferred Tax: -515000.00
CLNE cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 45674000.00
CLNE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 45674000.00
CLNE balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 0.00
CLNE income_statement (annual, 2023-12-31) — Diluted Average Shares: 222904785.00
CLNE income_statement (annual, 2023-12-31) — Diluted EPS: -0.45
CLNE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -99497000.00
CLNE income_statement (annual, 2023-12-31) — EBIT: -77597000.00
CLNE income_statement (annual, 2023-12-31) — EBITDA: -31923000.00
CLNE income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -12510000.00
CLNE cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 12510000.00
CLNE cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 128000.00
CLNE cash_flow (annual, 2023-12-31) — End Cash Position: 106963000.00
CLNE cash_flow (annual, 2023-12-31) — Financing Cash Flow: 139121000.00
CLNE cash_flow (annual, 2023-12-31) — Free Cash Flow: -77505000.00
CLNE cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 158000.00
CLNE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 863000.00
CLNE income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
CLNE balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -2119000.00
CLNE balance_sheet (annual, 2023-12-31) — Goodwill: 64328000.00
CLNE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 70693000.00
CLNE balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 99901000.00
CLNE balance_sheet (annual, 2023-12-31) — Gross PPE: 916222000.00
CLNE income_statement (annual, 2023-12-31) — Gross Profit: 35865000.00
CLNE income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CLNE cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 77000.00
CLNE income_statement (annual, 2023-12-31) — Interest Expense: 22924000.00
CLNE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 22924000.00
CLNE income_statement (annual, 2023-12-31) — Interest Income: 11148000.00
CLNE income_statement (annual, 2023-12-31) — Interest Income Non Operating: 11148000.00
CLNE cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 16360000.00
CLNE balance_sheet (annual, 2023-12-31) — Interest Payable: 1451000.00
CLNE balance_sheet (annual, 2023-12-31) — Inventory: 45335000.00
CLNE balance_sheet (annual, 2023-12-31) — Invested Capital: 987931000.00
CLNE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -202013000.00
CLNE balance_sheet (annual, 2023-12-31) — Investments And Advances: 258773000.00
CLNE balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 258773000.00
CLNE cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 242000.00
CLNE cash_flow (annual, 2023-12-31) — Issuance Of Debt: 300255000.00
CLNE balance_sheet (annual, 2023-12-31) — Land And Improvements: 7397000.00
CLNE balance_sheet (annual, 2023-12-31) — Loans Receivable: 194000.00
CLNE balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 90904000.00
CLNE balance_sheet (annual, 2023-12-31) — Long Term Debt: 261123000.00
CLNE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 352027000.00
CLNE cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 300255000.00
CLNE cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -151148000.00
CLNE balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 258773000.00
CLNE balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 167328000.00
CLNE balance_sheet (annual, 2023-12-31) — Minority Interest: 6877000.00
CLNE income_statement (annual, 2023-12-31) — Minority Interests: 601000.00
CLNE cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -70226000.00
CLNE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 242000.00
CLNE balance_sheet (annual, 2023-12-31) — Net Debt: 156217000.00
CLNE income_statement (annual, 2023-12-31) — Net Income: -99497000.00
CLNE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -99497000.00
CLNE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -100098000.00
CLNE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -99497000.00
CLNE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -99497000.00
CLNE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -100098000.00
CLNE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -100098000.00
CLNE income_statement (annual, 2023-12-31) — Net Interest Income: -11776000.00
CLNE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -11965000.00
CLNE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 149107000.00
CLNE cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 149107000.00
CLNE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -11776000.00
CLNE cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -10228000.00
CLNE cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 1198000.00
CLNE balance_sheet (annual, 2023-12-31) — Net PPE: 424082000.00
CLNE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -121020000.00
CLNE cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
CLNE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 656077000.00
CLNE income_statement (annual, 2023-12-31) — Normalized EBITDA: -31923000.00
CLNE income_statement (annual, 2023-12-31) — Normalized Income: -99497000.00
CLNE balance_sheet (annual, 2023-12-31) — Notes Receivable: 2330000.00
CLNE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 43777000.00
CLNE cash_flow (annual, 2023-12-31) — Operating Gains Losses: 18898000.00
CLNE income_statement (annual, 2023-12-31) — Operating Income: -76400000.00
CLNE income_statement (annual, 2023-12-31) — Operating Revenue: 425159000.00
CLNE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 223026966.00
CLNE balance_sheet (annual, 2023-12-31) — Other Current Assets: 41495000.00
CLNE balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 38000.00
CLNE balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1875000.00
CLNE balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -2119000.00
CLNE income_statement (annual, 2023-12-31) — Other Income Expense: -12345000.00
CLNE balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 6365000.00
CLNE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2146000.00
CLNE balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 35735000.00
CLNE balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 9961000.00
CLNE income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 165000.00
CLNE balance_sheet (annual, 2023-12-31) — Other Properties: 616108000.00
CLNE balance_sheet (annual, 2023-12-31) — Other Receivables: 8370000.00
CLNE balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 158186000.00
CLNE balance_sheet (annual, 2023-12-31) — Payables: 56995000.00
CLNE balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 143214000.00
CLNE balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5315000.00
CLNE balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CLNE income_statement (annual, 2023-12-31) — Pretax Income: -100521000.00
CLNE balance_sheet (annual, 2023-12-31) — Properties: 0.00
CLNE cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 1773000.00
CLNE cash_flow (annual, 2023-12-31) — Purchase Of Business: -73450000.00
CLNE cash_flow (annual, 2023-12-31) — Purchase Of Investment: -491253000.00
CLNE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -121282000.00
CLNE balance_sheet (annual, 2023-12-31) — Raw Materials: 45335000.00
CLNE balance_sheet (annual, 2023-12-31) — Receivables: 118196000.00
CLNE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 389294000.00
CLNE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 45674000.00
CLNE cash_flow (annual, 2023-12-31) — Repayment Of Debt: -151148000.00
CLNE cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
CLNE balance_sheet (annual, 2023-12-31) — Restricted Cash: 2019000.00
CLNE balance_sheet (annual, 2023-12-31) — Retained Earnings: -929472000.00
CLNE cash_flow (annual, 2023-12-31) — Sale Of Business: 3224000.00
CLNE cash_flow (annual, 2023-12-31) — Sale Of Investment: 479288000.00
CLNE cash_flow (annual, 2023-12-31) — Sale Of PPE: 262000.00
CLNE income_statement (annual, 2023-12-31) — Selling General And Administration: 112265000.00
CLNE balance_sheet (annual, 2023-12-31) — Share Issued: 223026966.00
CLNE cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
CLNE cash_flow (annual, 2023-12-31) — Short Term Debt Payments: 0.00
CLNE income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CLNE cash_flow (annual, 2023-12-31) — Stock Based Compensation: 83945000.00
CLNE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 726770000.00
CLNE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 656077000.00
CLNE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CLNE income_statement (annual, 2023-12-31) — Tax Provision: -423000.00
CLNE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CLNE balance_sheet (annual, 2023-12-31) — Taxes Receivable: 8876000.00
CLNE balance_sheet (annual, 2023-12-31) — Total Assets: 1259458000.00
CLNE balance_sheet (annual, 2023-12-31) — Total Capitalization: 987893000.00
CLNE balance_sheet (annual, 2023-12-31) — Total Debt: 360510000.00
CLNE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 733647000.00
CLNE income_statement (annual, 2023-12-31) — Total Expenses: 501559000.00
CLNE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 525811000.00
CLNE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 789283000.00
CLNE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 361988000.00
CLNE income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -76400000.00
CLNE income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
CLNE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CLNE balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CLNE balance_sheet (annual, 2023-12-31) — Working Capital: 306352000.00
CLNE income_statement (annual, 2023-12-31) — Write Off: 0.00
CLNE cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
CLNE cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
CLNE balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 5161000.00
CLNE income_statement (annual, 2024-12-31) — +Operating Expense: 111834000.00
CLNE income_statement (annual, 2024-12-31) — +Total Revenue: 415865000.00
CLNE balance_sheet (annual, 2024-12-31) — Accounts Payable: 33301000.00
CLNE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 107683000.00
CLNE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -531564000.00
CLNE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1730090000.00
CLNE balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1965000.00
CLNE cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 8482000.00
CLNE income_statement (annual, 2024-12-31) — Basic Average Shares: 223346127.00
CLNE income_statement (annual, 2024-12-31) — Basic EPS: -0.37
CLNE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 106963000.00
CLNE cash_flow (annual, 2024-12-31) — Capital Expenditure: -79956000.00
CLNE balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 99762000.00
CLNE balance_sheet (annual, 2024-12-31) — Capital Stock: 22000.00
CLNE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 89512000.00
CLNE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 217482000.00
CLNE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1944000.00
CLNE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -77680000.00
CLNE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 64579000.00
CLNE cash_flow (annual, 2024-12-31) — Change In Account Payable: -18784000.00
CLNE cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 8045000.00
CLNE cash_flow (annual, 2024-12-31) — Change In Inventory: -57000.00
CLNE cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -6087000.00
CLNE cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 2205000.00
CLNE cash_flow (annual, 2024-12-31) — Change In Payable: -18784000.00
CLNE cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -10739000.00
CLNE cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 6033000.00
CLNE cash_flow (annual, 2024-12-31) — Change In Receivables: -8177000.00
CLNE cash_flow (annual, 2024-12-31) — Change In Working Capital: -16822000.00
CLNE cash_flow (annual, 2024-12-31) — Changes In Cash: -15045000.00
CLNE balance_sheet (annual, 2024-12-31) — Common Stock: 22000.00
CLNE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 713273000.00
CLNE cash_flow (annual, 2024-12-31) — Common Stock Issuance: 64000.00
CLNE cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 21000.00
CLNE cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
CLNE balance_sheet (annual, 2024-12-31) — Construction In Progress: 134057000.00
CLNE income_statement (annual, 2024-12-31) — Cost Of Revenue: 332282000.00
CLNE balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 93245000.00
CLNE balance_sheet (annual, 2024-12-31) — Current Assets: 413768000.00
CLNE balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 8947000.00
CLNE balance_sheet (annual, 2024-12-31) — Current Debt: 40000.00
CLNE balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 8987000.00
CLNE balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 6871000.00
CLNE balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 6871000.00
CLNE balance_sheet (annual, 2024-12-31) — Current Liabilities: 154722000.00
CLNE balance_sheet (annual, 2024-12-31) — Current Provisions: 7047000.00
CLNE balance_sheet (quarterly, 2024-12-31) — Current Provisions: 7047000.00
CLNE cash_flow (annual, 2024-12-31) — Deferred Income Tax: 2630000.00
CLNE cash_flow (annual, 2024-12-31) — Deferred Tax: 2630000.00
CLNE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 44737000.00
CLNE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 44737000.00
CLNE income_statement (annual, 2024-12-31) — Diluted Average Shares: 223346127.00
CLNE income_statement (annual, 2024-12-31) — Diluted EPS: -0.37
CLNE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -83070000.00
CLNE income_statement (annual, 2024-12-31) — EBIT: -48818000.00
CLNE income_statement (annual, 2024-12-31) — EBITDA: -4081000.00
CLNE income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -26576000.00
CLNE cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 26576000.00
CLNE cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -356000.00
CLNE cash_flow (annual, 2024-12-31) — End Cash Position: 91562000.00
CLNE cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1944000.00
CLNE cash_flow (annual, 2024-12-31) — Free Cash Flow: -15377000.00
CLNE cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 131000.00
CLNE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 468000.00
CLNE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -4297000.00
CLNE balance_sheet (annual, 2024-12-31) — Goodwill: 64328000.00
CLNE balance_sheet (quarterly, 2024-12-31) — Goodwill: 64328000.00
CLNE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 70693000.00
CLNE balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 109648000.00
CLNE balance_sheet (annual, 2024-12-31) — Gross PPE: 987481000.00
CLNE income_statement (annual, 2024-12-31) — Gross Profit: 83583000.00
CLNE income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CLNE cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 60000.00
CLNE income_statement (annual, 2024-12-31) — Interest Expense: 32179000.00
CLNE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 32179000.00
CLNE income_statement (annual, 2024-12-31) — Interest Income: 14005000.00
CLNE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 14005000.00
CLNE cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 27402000.00
CLNE balance_sheet (annual, 2024-12-31) — Interest Payable: 1451000.00
CLNE balance_sheet (annual, 2024-12-31) — Inventory: 43434000.00
CLNE balance_sheet (annual, 2024-12-31) — Invested Capital: 978640000.00
CLNE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -77680000.00
CLNE balance_sheet (annual, 2024-12-31) — Investments And Advances: 265268000.00
CLNE balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 265268000.00
CLNE cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 64000.00
CLNE cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 21000.00
CLNE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
CLNE cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
CLNE balance_sheet (annual, 2024-12-31) — Land And Improvements: 19193000.00
CLNE balance_sheet (annual, 2024-12-31) — Loans Receivable: 81000.00
CLNE balance_sheet (quarterly, 2024-12-31) — Loans Receivable: 81000.00
CLNE balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 90815000.00
CLNE balance_sheet (annual, 2024-12-31) — Long Term Debt: 265327000.00
CLNE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 356142000.00
CLNE cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
CLNE cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
CLNE cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2234000.00
CLNE balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 265268000.00
CLNE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 167175000.00
CLNE balance_sheet (annual, 2024-12-31) — Minority Interest: 6258000.00
CLNE income_statement (annual, 2024-12-31) — Minority Interests: 619000.00
CLNE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -25912000.00
CLNE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 64000.00
CLNE balance_sheet (annual, 2024-12-31) — Net Debt: 175855000.00
CLNE income_statement (annual, 2024-12-31) — Net Income: -83070000.00
CLNE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -83070000.00
CLNE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -83689000.00
CLNE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -83070000.00
CLNE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -83070000.00
CLNE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -83689000.00
CLNE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -83689000.00
CLNE income_statement (annual, 2024-12-31) — Net Interest Income: -18174000.00
CLNE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 36434000.00
CLNE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -2234000.00
CLNE cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -2234000.00
CLNE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -18174000.00
CLNE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 226000.00
CLNE cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -8822000.00
CLNE balance_sheet (annual, 2024-12-31) — Net PPE: 455917000.00
CLNE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -79380000.00
CLNE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 642580000.00
CLNE income_statement (annual, 2024-12-31) — Normalized EBITDA: 4021000.00
CLNE income_statement (annual, 2024-12-31) — Normalized Income: -76669420.00
CLNE balance_sheet (annual, 2024-12-31) — Notes Receivable: 2372000.00
CLNE balance_sheet (quarterly, 2024-12-31) — Notes Receivable: 2372000.00
CLNE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 64579000.00
CLNE cash_flow (annual, 2024-12-31) — Operating Gains Losses: 27175000.00
CLNE income_statement (annual, 2024-12-31) — Operating Income: -28251000.00
CLNE income_statement (annual, 2024-12-31) — Operating Revenue: 415865000.00
CLNE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 223456994.00
CLNE balance_sheet (annual, 2024-12-31) — Other Current Assets: 26117000.00
CLNE balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 40000.00
CLNE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -4297000.00
CLNE income_statement (annual, 2024-12-31) — Other Income Expense: -34572000.00
CLNE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 6365000.00
CLNE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 7817000.00
CLNE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 38245000.00
CLNE balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 13496000.00
CLNE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 106000.00
CLNE balance_sheet (annual, 2024-12-31) — Other Properties: 667056000.00
CLNE balance_sheet (annual, 2024-12-31) — Other Receivables: 3798000.00
CLNE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 127970000.00
CLNE balance_sheet (annual, 2024-12-31) — Payables: 33301000.00
CLNE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 126546000.00
CLNE balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5271000.00
CLNE balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CLNE income_statement (annual, 2024-12-31) — Pretax Income: -80997000.00
CLNE balance_sheet (annual, 2024-12-31) — Properties: 0.00
CLNE cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 2682000.00
CLNE cash_flow (annual, 2024-12-31) — Purchase Of Business: -32892000.00
CLNE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -914210000.00
CLNE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -79956000.00
CLNE balance_sheet (annual, 2024-12-31) — Raw Materials: 43434000.00
CLNE balance_sheet (annual, 2024-12-31) — Receivables: 124685000.00
CLNE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 332282000.00
CLNE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 44737000.00
CLNE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2234000.00
CLNE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CLNE balance_sheet (annual, 2024-12-31) — Restricted Cash: 2050000.00
CLNE balance_sheet (annual, 2024-12-31) — Retained Earnings: -1012542000.00
CLNE cash_flow (annual, 2024-12-31) — Sale Of Business: 6980000.00
CLNE cash_flow (annual, 2024-12-31) — Sale Of Investment: 950644000.00
CLNE cash_flow (annual, 2024-12-31) — Sale Of PPE: 576000.00
CLNE income_statement (annual, 2024-12-31) — Selling General And Administration: 111834000.00
CLNE balance_sheet (annual, 2024-12-31) — Share Issued: 223456994.00
CLNE income_statement (annual, 2024-12-31) — Special Income Charges: -8102000.00
CLNE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 71567000.00
CLNE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 713273000.00
CLNE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 642580000.00
CLNE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -1701420.00
CLNE income_statement (annual, 2024-12-31) — Tax Provision: 2692000.00
CLNE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CLNE balance_sheet (annual, 2024-12-31) — Taxes Receivable: 10751000.00
CLNE balance_sheet (annual, 2024-12-31) — Total Assets: 1243891000.00
CLNE balance_sheet (annual, 2024-12-31) — Total Capitalization: 978600000.00
CLNE balance_sheet (annual, 2024-12-31) — Total Debt: 365129000.00
CLNE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 719531000.00
CLNE income_statement (annual, 2024-12-31) — Total Expenses: 444116000.00
CLNE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 524360000.00
CLNE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 830123000.00
CLNE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 369638000.00
CLNE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -36353000.00
CLNE income_statement (annual, 2024-12-31) — Total Unusual Items: -8102000.00
CLNE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -8102000.00
CLNE balance_sheet (annual, 2024-12-31) — Working Capital: 259046000.00
CLNE income_statement (annual, 2024-12-31) — Write Off: 8102000.00
CLNE income_statement (quarterly, 2025-03-31) — +Operating Expense: 27464000.00
CLNE income_statement (quarterly, 2025-03-31) — +Total Revenue: 103764000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 30144000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 91415000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -538937000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1748540000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1973000.00
CLNE cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 64328000.00
CLNE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 223673947.00
CLNE income_statement (quarterly, 2025-03-31) — Basic EPS: -0.60
CLNE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 91562000.00
CLNE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -18590000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 96691000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 22000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 118565000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 226625000.00
CLNE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1924000.00
CLNE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 7397000.00
CLNE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 23428000.00
CLNE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -4708000.00
CLNE cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -4500000.00
CLNE cash_flow (quarterly, 2025-03-31) — Change In Inventory: -1957000.00
CLNE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -2002000.00
CLNE cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 933000.00
CLNE cash_flow (quarterly, 2025-03-31) — Change In Payable: -4708000.00
CLNE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -9208000.00
CLNE cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 29000.00
CLNE cash_flow (quarterly, 2025-03-31) — Change In Receivables: 15335000.00
CLNE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 3130000.00
CLNE cash_flow (quarterly, 2025-03-31) — Changes In Cash: 28901000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Common Stock: 22000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 596704000.00
CLNE cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 52000.00
CLNE cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -391000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 87466000.00
CLNE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 138270000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 87452000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Current Assets: 408689000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 9064000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Current Debt: 47000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 9111000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 7823000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 7823000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 144990000.00
CLNE cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -2955000.00
CLNE cash_flow (quarterly, 2025-03-31) — Deferred Tax: -2955000.00
CLNE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 62267000.00
CLNE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 62267000.00
CLNE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 223673947.00
CLNE income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.60
CLNE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -134967000.00
CLNE income_statement (quarterly, 2025-03-31) — EBIT: -130435000.00
CLNE income_statement (quarterly, 2025-03-31) — EBITDA: -68168000.00
CLNE income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -7044000.00
CLNE cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 7044000.00
CLNE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 216000.00
CLNE cash_flow (quarterly, 2025-03-31) — End Cash Position: 120679000.00
CLNE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1924000.00
CLNE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 4838000.00
CLNE cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 557000.00
CLNE cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 2805000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -4349000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Goodwill: 0.00
CLNE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 5500000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 93388000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 945344000.00
CLNE income_statement (quarterly, 2025-03-31) — Gross Profit: -34506000.00
CLNE income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 64328000.00
CLNE cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 2000.00
CLNE income_statement (quarterly, 2025-03-31) — Interest Expense: 7528000.00
CLNE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 7528000.00
CLNE income_statement (quarterly, 2025-03-31) — Interest Income: 2899000.00
CLNE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2899000.00
CLNE cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 6262000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Interest Payable: 1453000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Inventory: 45720000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 868329000.00
CLNE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 7397000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 259474000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 259474000.00
CLNE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 52000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 18543000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Loans Receivable: 83000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 87627000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 271578000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 359205000.00
CLNE cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -256000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 259474000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 167190000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Minority Interest: 6194000.00
CLNE income_statement (quarterly, 2025-03-31) — Minority Interests: 64000.00
CLNE cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 1385000.00
CLNE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -339000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Net Debt: 153060000.00
CLNE income_statement (quarterly, 2025-03-31) — Net Income: -134967000.00
CLNE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -134967000.00
CLNE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -135031000.00
CLNE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -134967000.00
CLNE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -134967000.00
CLNE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -135031000.00
CLNE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -135031000.00
CLNE income_statement (quarterly, 2025-03-31) — Net Interest Income: -4629000.00
CLNE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 21085000.00
CLNE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -256000.00
CLNE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -256000.00
CLNE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -4629000.00
CLNE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1329000.00
CLNE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -1481000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Net PPE: 406407000.00
CLNE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -13592000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 591204000.00
CLNE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -3840000.00
CLNE income_statement (quarterly, 2025-03-31) — Normalized Income: -72006103.47
CLNE balance_sheet (quarterly, 2025-03-31) — Notes Receivable: 2638000.00
CLNE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 23428000.00
CLNE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 10406000.00
CLNE income_statement (quarterly, 2025-03-31) — Operating Income: -61970000.00
CLNE income_statement (quarterly, 2025-03-31) — Operating Revenue: 103764000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 223736131.00
CLNE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 24863000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 47000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -4349000.00
CLNE income_statement (quarterly, 2025-03-31) — Other Income Expense: -71364000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 5500000.00
CLNE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1973000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 36522000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 9499000.00
CLNE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 8000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Other Properties: 672145000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Other Receivables: 4560000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 108060000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Payables: 36503000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 123955000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4101000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CLNE income_statement (quarterly, 2025-03-31) — Pretax Income: -137963000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CLNE cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 195000.00
CLNE cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
CLNE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -363240000.00
CLNE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -18590000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Raw Materials: 45720000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Receivables: 109367000.00
CLNE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 138270000.00
CLNE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 62267000.00
CLNE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -256000.00
CLNE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -391000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 2114000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1147509000.00
CLNE cash_flow (quarterly, 2025-03-31) — Sale Of Business: 1385000.00
CLNE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 384325000.00
CLNE cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 4998000.00
CLNE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 27464000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Share Issued: 223736131.00
CLNE income_statement (quarterly, 2025-03-31) — Special Income Charges: -64328000.00
CLNE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 19115000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 596704000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 591204000.00
CLNE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -1367103.47
CLNE income_statement (quarterly, 2025-03-31) — Tax Provision: -2932000.00
CLNE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.02
CLNE balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 10671000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Total Assets: 1116592000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 868282000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Total Debt: 368316000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 602898000.00
CLNE income_statement (quarterly, 2025-03-31) — Total Expenses: 165734000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 513694000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 707903000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 368704000.00
CLNE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -126298000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 6359000.00
CLNE income_statement (quarterly, 2025-03-31) — Total Unusual Items: -64328000.00
CLNE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -64328000.00
CLNE balance_sheet (quarterly, 2025-03-31) — Working Capital: 263699000.00
CLNE income_statement (quarterly, 2025-06-30) — +Operating Expense: 27453000.00
CLNE income_statement (quarterly, 2025-06-30) — +Total Revenue: 102613000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 28492000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 82861000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -544424000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1760813000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -2173000.00
CLNE cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
CLNE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 220393997.00
CLNE income_statement (quarterly, 2025-06-30) — Basic EPS: -0.09
CLNE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 120679000.00
CLNE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -14708000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 95901000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 22000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 132089000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 240758000.00
CLNE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -8277000.00
CLNE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -14044000.00
CLNE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 35901000.00
CLNE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -1370000.00
CLNE cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 5179000.00
CLNE cash_flow (quarterly, 2025-06-30) — Change In Inventory: -808000.00
CLNE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1821000.00
CLNE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 994000.00
CLNE cash_flow (quarterly, 2025-06-30) — Change In Payable: -1370000.00
CLNE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 3809000.00
CLNE cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -580000.00
CLNE cash_flow (quarterly, 2025-06-30) — Change In Receivables: 14736000.00
CLNE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 16330000.00
CLNE cash_flow (quarterly, 2025-06-30) — Changes In Cash: 13580000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Common Stock: 22000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 590821000.00
CLNE cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CLNE cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -7547000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 101364000.00
CLNE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 84392000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 84002000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Current Assets: 407866000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 9337000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Current Debt: 49000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 9386000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 8836000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 8836000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 144252000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Current Provisions: 8838000.00
CLNE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 50000.00